Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis C

Free Subscription Articles published in Gut Retrieve available abstracts of 45 articles: HTML format Text format

Single Articles

September 2011
1. DEUFFIC-BURBAN S , Mathurin P, Pol S, Larsen C, et al
   Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. KELLY C , Klenerman P, Barnes E
   Interferon lambdas: the next cytokine storm.
   Gut. 2011;60:1284-93.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
3. KLENERMAN P , Thimme R
   T cell responses in hepatitis C: the good, the bad and the unconventional.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. THOMPSON AJ , Patel K, Chuang WL, Lawitz EJ, et al
   Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BRENNDORFER ED , Brass A, Soderholm J, Frelin L, et al
   Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-{gamma} production.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
6. FITZMAURICE K , Petrovic D, Ramamurthy N, Simmons R, et al
   Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2011
7. CARDOSO AC , Carvalho-Filho RJ, Marcellin P
   Transient elastography in chronic viral hepatitis: a critical appraisal.
   Gut. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
8. MELGAR-LESMES P , Pauta M, Reichenbach V, Casals G, et al
   Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2011
9. MIQUILENA-COLINA ME , Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, et al
   Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. EL-SERAG HB , Kramer JR, Chen GJ, Duan Z, et al
    Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. ESLAM M , Khattab MA, Harrison SA
    Insulin resistance and hepatitis C: an evolving story.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
12. THOMSON EC , Fleming VM, Main J, Klenerman P, et al
    Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
13. HAYES CN , Kobayashi M, Akuta N, Suzuki F, et al
    HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. LEE MH , Yang HI, Jen CL, Lu SN, et al
    Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991-2.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. PAEZ JIMENEZ A , Sharaf Eldin N, Rimlinger F, El-Daly M, et al
    HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt.
    Gut. 2010;59:1554-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
16. PATEL H , Heathcote EJ
    Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
17. SVEGLIATI-BARONI G , Faraci G, Fabris L, Saccomanno S, et al
    Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BARDOU-JACQUET E , Lorho R, Guyader D
    Kinase inhibitors in the treatment of chronic hepatitis C virus.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
19. BRIDGE SH , Sheridan DA, Felmlee DJ, Nielsen SU, et al
    Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MANCONE C , Steindler C, Santangelo L, Simonte G, et al
    Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. NEGRO F
    Cause-effect relationship between the hepatitis C virus and insulin resistance at the time of direct antiviral therapy.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
22. BOKEMEYER M , Ding XQ, Goldbecker A, Raab P, et al
    Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. MALIK R , Schuppan D
    Serum fibrosis markers to predict clinical and histological progression in hepatitis C non-responders.
    Gut. 2010;59:1312-3.
    PubMed     Text format     Related articles   
    
    
    
    
24. BEAUGERIE L , Gerbes AL
    Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear?
    Gut. 2010;59:1310-1.
    PubMed     Text format     Related articles   
    
    
    
    
25. STEPANOVA M , Rafiq N, Younossi ZM
    Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
    Gut. 2010;59:1410-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
26. CHEENT K , Khakoo SI
    Natural killer cells and hepatitis C: action and reaction.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. MOUCARI R , Forestier N, Larrey D, Guyader D, et al
    Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. TERRIER B , Saadoun D, Sene D, Scerra S, et al
    Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case-control study from a single-centre cohort of 163 patients.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
29. SACCHI A , Agrati C, D'Offizi G, Vlassi C, et al
    Co-stimulatory molecule CD80 expression may correlate with anti-HCV treatment outcome.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
30. BROERING R , Zhang X, Kottilil S, Trippler M, et al
    The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.
    Gut. 2010;59:1111-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. ESTRABAUD E , Asselah T
    Interferon-stimulated gene 15: a dual activity during hepatitis C virus infection.
    Gut. 2010;59:1017-9.
    PubMed     Text format     Related articles   
    
    
    
    
32. AHMED F , Foster GR
    Global hepatitis, migration and its impact on Western healthcare.
    Gut. 2010;59:1009-11.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
33. WILKINSON J , Radkowski M, Eschbacher JM, Laskus T, et al
    Activation of brain macrophages/microglia cells in hepatitis C infection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. FONTANA RJ , Dienstag JL, Bonkovsky HL, Sterling RK, et al
    Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. NEGRO F
    Abnormalities of lipid metabolism in hepatitis C virus infection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. ROHRBACH J , Robinson N, Harcourt G, Hammond E, et al
    Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. DIEPOLDER H , Gruener N
    Evolution of cellular immune responses to hepatitis C virus during antiretroviral therapy and its clinical implications.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
38. MICHALAK TI
    Immune cell reservoirs of persisting hepatitis C virus.
    Gut. 2010;59:867-8.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
39. NALPAS B , Lavialle-Meziani R, Plancoulaine S, Jouanguy E, et al
    Interferon {gamma} receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. MOSTAFA A , Mohamed MK, Saeed M, Hasan A, et al
    Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. LORAS C , Gisbert JP, Minguez M, Merino O, et al
    Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
42. DURAND T , Di Liberto G, Colman H, Cammas A, et al
    Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. LORENZINI S , Bird TG, Boulter L, Bellamy C, et al
    Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver.
    Gut. 2010;59:645-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
44. DAI CY , Huang JF, Hsieh MY, Chuang WL, et al
    Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
    Gut. 2010;59:418.
    PubMed     Text format     Related articles   
    
    
    
    January 2010
45. WOLTMAN AM , Boonstra A, Janssen HL
    Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?
    Gut. 2010;59:115-25.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.    Design: